FundLens

Best Contra Funds

Against-the-herd positioning in out-of-favour sectors and stocks.

Data updated · 5 direct-growth funds ranked by a transparent 0–100 Smart Score

5
Funds
0
Strong Buys
High
Risk
5 funds
Want to compare funds? Tick the checkbox in the first column — pick up to 5 and they'll go head-to-head in one view.
⚖ VSFund Score Verdict1Y 3Y 5Y Sharpe Sortino Std Dev Alpha Beta VR★ P/E Expense AUM Age
Kotak Contra
Kotak
68
Buy-0.1%14.9%14.2%0.770.7815.63.90.994★22.70.79%₹5.5k Cr13.7y
Bandhan Contra
Bandhan
52
Hold0.49%₹0 Cr0.1y
SBI Contra
SBI
44
Avoid-3.5%10.5%14.8%0.550.4214.10.30.892★16.90.86%₹47.6k Cr13.7y
Invesco India Contra
Invesco
43
Avoid-2.6%13.8%13.1%0.730.6715.93.41.005★28.30.77%₹20.6k Cr13.7y
Motilal Oswal Contra
Motilal Oswal
19
Avoid37.22.34%₹446 Cr0.4y
Reading the ratios: ↑ higher is better — Returns, Sharpe, Sortino, Alpha · ↓ lower is better — Std Dev, P/E, Expense · Beta ≈1 moves with the market (<1 swings less). Hover any column header for details.

Contra funds — quick answers

Which is the best Contra mutual fund right now?

Kotak Contra currently ranks #1 of 5 Contra funds with a FundLens Smart Score of 68/100 (Buy). It returned 14.9% over 3 years and 14.2% over 5 years at a 0.79% expense ratio (direct plan). Rankings are recomputed from data updated 20 Sept 2026.

Which Contra fund has the best risk-adjusted returns?

Kotak Contra leads the category on the Sortino ratio at 0.78 (Sharpe 0.77) — meaning it has delivered the most return per unit of downside risk among Contra funds.

Which Contra fund has the lowest expense ratio?

Bandhan Contra charges 0.49% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.

Which is the smallest Contra fund by AUM?

Bandhan Contra manages ₹0 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.

How long should I stay invested in a Contra fund?

Contra funds carry high risk, so a horizon of 5+ years is generally sensible. Against-the-herd positioning in out-of-favour sectors and stocks. This is research, not investment advice.

Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained